ArticleClinical nephrology2022

Comparative efficacy of ravulizumab and eculizumab in the treatment of atypical hemolytic uremic syndrome: An indirect comparison using clinical trial data.

Ioannis Tomazos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.